The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria

FEBS Letters
Yuki TamuraHiroyuki Osada

Abstract

Bcl-2 protein play important roles in the regulation of apoptosis. We previously reported that the phosphorylation of Bcl-2 was augmented by treatment with protein phosphatase 2A (PP2A) inhibitor; however, the kinase responsible for Bcl-2 phosphorylation had not yet been identified. In this study, we identified extracellular-signal-regulated kinase (ERK) as the responsible kinase for the phosphorylation of Bcl-2. We also found that the transmembrane region (TM) deleted form of Bcl-2 (Bcl-2DeltaTM), which was unable to localize on the mitochondria was constitutively phosphorylated, whereas wild-type Bcl-2 that localized on the mitochondria, was present in its hypophosphorylated form. The phosphorylation of Bcl-2DeltaTM was retarded by treatment with MAP kinase ERK kinase (MEK) inhibitor and PP2A did not bind to Bcl-2DeltaTM. These observations suggest that Bcl-2DeltaTM is constitutively phosphorylated by ERK, but is not dephosphorylated by PP2A in human tumor cell lines. The phosphorylation of Bcl-2 resulted in a reduction in anti-apoptotic function, implying that dephosphorylation promoted the anti-apoptotic activity of Bcl-2 protein in human tumor cell lines. Thus, the present findings suggest that ERK and PP2A are physiologic...Continue Reading

References

Jan 1, 1980·International Review of Cytology·A H WyllieA R Currie
Nov 24, 1995·Science·Z XiaM E Greenberg
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·S HaldarC M Croce
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·M LamC W Distelhorst
May 2, 1997·The Journal of Biological Chemistry·T ItoW S May
May 23, 1998·Annual Review of Immunology·D T Chao, S J Korsmeyer
Jul 21, 1998·The Journal of Biological Chemistry·Y H LingR Perez-Soler
Nov 7, 1998·The Journal of Biological Chemistry·C D ScatenaJ A Pietenpol
Jan 16, 1999·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·C A SchandlM C Willingham
Jul 10, 1999·The Journal of Biological Chemistry·P P RuvoloW S May
Dec 22, 1999·Biochemical and Biophysical Research Communications·Y Miyata, E Nishida
Jan 29, 2000·FEBS Letters·Y Tsujimoto, S Shimizu
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·X DengW S May
Apr 15, 2000·The Journal of Biological Chemistry·Y FurukawaM Matsuda
May 10, 2000·Nature Medicine·G Kroemer, J C Reed
Mar 10, 2001·Nature·L Chang, M Karin
May 18, 2001·Nature·P Blume-Jensen, T Hunter
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Dec 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xingming DengW Stratford May

❮ Previous
Next ❯

Citations

Jun 1, 2005·Toxicon : Official Journal of the International Society on Toxinology·Wen-yu FuLi-hong Xu
Dec 26, 2008·Biology of Reproduction·Yue JiaAmiya P Sinha-Hikim
May 19, 2005·Molecular and Cellular Biology·Xue WangAugustine M K Choi
Jul 23, 2011·Genes & Cancer·Inbal Wortzel, Rony Seger
Aug 3, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Chee Yeun ChungOle Isacson
May 14, 2014·International Journal of Molecular Medicine·Li XueYanjiong Chen
Sep 19, 2009·Nutritional Neuroscience·Xu-Mei ZhangJohn X Wilson
May 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hirokazu OhtakiSeiji Shioda
Mar 7, 2006·Critical Reviews in Clinical Laboratory Sciences·Ming-Yue LiGeorge G Chen
Jul 2, 2009·Free Radical Research·Thomais MarkouAntigone Lazou
Feb 2, 2016·Current Opinion in Cell Biology·Ehud Wainstein, Rony Seger
Aug 2, 2011·Biotechnology Advances·F ChiaradonnaL Alberghina
Jan 14, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Robert MellerRoger P Simon
Jul 30, 2008·Experimental Cell Research·Ngit Shin LaiHiroyuki Osada
Feb 28, 2008·Experimental Neurology·Diana M CittellyJ Regino Perez-Polo
Feb 23, 2005·Cancer Science·Yukitoshi NagaharaMasahiko Ikekita
Jul 19, 2008·Cancer Science·Yukihiro AsamiHiroyuki Osada
Dec 14, 2004·Free Radical Biology & Medicine·Craig Horbinski, Charleen T Chu
Jan 18, 2006·The Journal of Steroid Biochemistry and Molecular Biology·Vasilia-Ismini AlexakiElias Castanas
Sep 29, 2005·Biochemical and Biophysical Research Communications·Tsung-Yao LinCheng-Deng Kuo
Jun 15, 2005·Trends in Cell Biology·Maya SalehDouglas R Green
Aug 16, 2016·Mitochondrion·Rikke Kruse, Kurt Højlund
Apr 18, 2018·Journal of Alzheimer's Disease : JAD·Sarah GourmaudJacques Hugon
May 27, 2017·The FEBS Journal·Simon J CookMatthew J Sale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis